Doctor Jeson R, Solanki Sohan Lal, Jain Arihant Ravi, Patil Vijaya P
Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Turk J Anaesthesiol Reanim. 2022 Feb;50(1):68-71. doi: 10.5152/TJAR.2021.1118.
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a well-established multimodal treatment in patients with peritoneal surface malignancies in adults. Children younger than 3 years rarely undergo such extensive surgeries with heated chemotherapy infusion intraoperatively. Only one such case is reported in the literature for CRS-HIPEC for an abdominopelvic rhabdomyosarcoma in a child of 2 years or less. We present the case of a 2-year-old child with abdominopelvic rhabdomyosarcoma undergoing CRS-HIPEC and discuss the perioperative concerns and challenges.
细胞减灭术（CRS）联合腹腔内热灌注化疗（HIPEC）是治疗成人腹膜表面恶性肿瘤的一种成熟的多模式治疗方法。3岁以下的儿童很少在术中接受如此广泛的手术及热化疗灌注。文献中仅报道过1例2岁及以下儿童因腹盆腔横纹肌肉瘤接受CRS-HIPEC治疗的病例。我们报告了1例2岁腹盆腔横纹肌肉瘤患儿接受CRS-HIPEC治疗的病例，并讨论围手术期的关注点和挑战。
